Half-year report · HY

Period2025-04-01 → 2025-09-30
Filed2025-11-12
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥17.9bn2025-04-01 → 2025-09-30Cons.Net sales
Revenue¥39.4bn2024-04-01 → 2025-03-31Cons.Net sales (5-year summary)
Revenue¥20.2bn2024-04-01 → 2024-09-30Cons.Net sales
Operating income−¥557m2025-04-01 → 2025-09-30Cons.Operating income
Operating income¥2.5bn2024-04-01 → 2024-09-30Cons.Operating income
Ordinary income¥531m2025-04-01 → 2025-09-30Cons.Ordinary income
Ordinary income¥1.9bn2024-04-01 → 2025-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥2.4bn2024-04-01 → 2024-09-30Cons.Ordinary income
Profit before tax¥361m2025-04-01 → 2025-09-30Cons.Income before income taxes
Profit before tax¥2.4bn2024-04-01 → 2024-09-30Cons.Income before income taxes
Net income (owners)¥229m2025-04-01 → 2025-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥1.2bn2024-04-01 → 2025-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥1.9bn2024-04-01 → 2024-09-30Cons.Profit loss attributable to owners of parent
Net income¥229m2025-04-01 → 2025-09-30Cons.Profit loss
Net income¥1.9bn2024-04-01 → 2024-09-30Cons.Profit loss
Total assets¥81.9bnat 2025-09-30Cons.Assets
Total assets¥83.9bnat 2025-03-31Cons.Assets
Total assets¥84.4bnat 2024-09-30Cons.Total assets (5-year summary)
Total liabilities¥9.7bnat 2025-09-30Cons.Liabilities
Total liabilities¥10.7bnat 2025-03-31Cons.Liabilities
Net assets / equity¥72.2bnat 2025-09-30Cons.Net assets
Net assets / equity¥73.2bnat 2025-03-31Cons.Net assets
Net assets / equity¥75.3bnat 2024-09-30Cons.Net assets (5-year summary)
Cash and deposits¥9.1bnat 2025-09-30Cons.Cash and deposits
Cash and deposits¥15.1bnat 2025-03-31Cons.Cash and deposits
Cash & equivalents¥12.3bnat 2025-09-30Cons.Cash and cash equivalents
Cash & equivalents¥18.3bnat 2025-03-31Cons.Cash and cash equivalents
Cash & equivalents¥19.8bnat 2024-09-30Cons.Cash and cash equivalents
Cash & equivalents¥18.7bnat 2024-03-31vCons.Cash and cash equivalents
Operating cash flow−¥1.3bn2025-04-01 → 2025-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥4.4bn2024-04-01 → 2025-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥3.0bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥3.6bn2025-04-01 → 2025-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥3.5bn2024-04-01 → 2025-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥1.4bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥838m2025-04-01 → 2025-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥1.6bn2024-04-01 → 2025-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥732m2024-04-01 → 2024-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥4.212025-04-01 → 2025-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥22.252024-04-01 → 2025-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥35.392024-04-01 → 2024-09-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio88.2%at 2025-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio87.3%at 2025-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio89.2%at 2024-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 18
SegmentItemPeriodValue
LALreportable segmentrevenue2025-04-01 → 2025-09-30¥5.8bn
LALreportable segmentrevenue external2025-04-01 → 2025-09-30¥5.8bn
LALreportable segmentsegment profit2025-04-01 → 2025-09-30¥178m
Pharmaceuticalreportable segmentrevenue2025-04-01 → 2025-09-30¥12.1bn
Pharmaceuticalreportable segmentrevenue external2025-04-01 → 2025-09-30¥12.1bn
Pharmaceuticalreportable segmentsegment profit2025-04-01 → 2025-09-30−¥735m
—segment totalrevenue2025-04-01 → 2025-09-30¥17.9bn
—segment totalrevenue external2025-04-01 → 2025-09-30¥17.9bn
—segment totalsegment profit2025-04-01 → 2025-09-30−¥557m
LALreportable segmentrevenue2024-04-01 → 2024-09-30¥5.9bn
LALreportable segmentrevenue external2024-04-01 → 2024-09-30¥5.9bn
LALreportable segmentsegment profit2024-04-01 → 2024-09-30¥481m
Pharmaceuticalreportable segmentrevenue2024-04-01 → 2024-09-30¥14.3bn
Pharmaceuticalreportable segmentrevenue external2024-04-01 → 2024-09-30¥14.3bn
Pharmaceuticalreportable segmentsegment profit2024-04-01 → 2024-09-30¥2.1bn
—segment totalrevenue2024-04-01 → 2024-09-30¥20.2bn
—segment totalrevenue external2024-04-01 → 2024-09-30¥20.2bn
—segment totalsegment profit2024-04-01 → 2024-09-30¥2.5bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 528
ItemContextValueUnit
Loss on retirement of noncurrent assets noePrior1InterimDuration11000000JPY
Loss on retirement of noncurrent assets noeInterimDuration2000000JPY
Taxes and dues noePrior1InterimDuration-JPY
Taxes and dues noeInterimDuration3000000JPY
Other noePrior1InterimDuration1000000JPY
Other noeInterimDuration1000000JPY
Non operating expensesPrior1InterimDuration516000000JPY
Non operating expensesInterimDuration11000000JPY
Ordinary incomePrior1InterimDuration2354000000JPY
Ordinary incomeInterimDuration531000000JPY
Impairment loss elPrior1InterimDuration-JPY
Impairment loss elInterimDuration169000000JPY
Extraordinary lossPrior1InterimDuration-JPY
Extraordinary lossInterimDuration169000000JPY
Income before income taxesPrior1InterimDuration2354000000JPY
Income before income taxesInterimDuration361000000JPY
Income taxes currentPrior1InterimDuration305000000JPY
Income taxes currentInterimDuration119000000JPY
Income taxes deferredPrior1InterimDuration117000000JPY
Income taxes deferredInterimDuration11000000JPY
Income taxesPrior1InterimDuration422000000JPY
Income taxesInterimDuration131000000JPY
Profit lossPrior1InterimDuration1931000000JPY
Profit lossInterimDuration229000000JPY
Profit loss attributable to owners of parentPrior1InterimDuration1931000000JPY
Profit loss attributable to owners of parentInterimDuration229000000JPY
Profit lossPrior1InterimDuration1931000000JPY
Profit lossInterimDuration229000000JPY
Valuation difference on available for sale securities net of tax ociPrior1InterimDuration-234000000JPY
Valuation difference on available for sale securities net of tax ociInterimDuration847000000JPY
Foreign currency translation adjustment net of tax ociPrior1InterimDuration2081000000JPY
Foreign currency translation adjustment net of tax ociInterimDuration-1150000000JPY
Remeasurements of defined benefit plans net of tax ociPrior1InterimDuration-75000000JPY
Remeasurements of defined benefit plans net of tax ociInterimDuration-67000000JPY
Other comprehensive incomePrior1InterimDuration1770000000JPY
Other comprehensive incomeInterimDuration-370000000JPY
Comprehensive incomePrior1InterimDuration3701000000JPY
Comprehensive incomeInterimDuration-140000000JPY
Comprehensive income attributable to owners of the parentPrior1InterimDuration3701000000JPY
Comprehensive income attributable to owners of the parentInterimDuration-140000000JPY
Comprehensive income attributable to non controlling interestsPrior1InterimDuration-JPY
Comprehensive income attributable to non controlling interestsInterimDuration-JPY
Income before income taxesPrior1InterimDuration2354000000JPY
Income before income taxesInterimDuration361000000JPY
Depreciation and amortization ope cfPrior1InterimDuration870000000JPY
Depreciation and amortization ope cfInterimDuration960000000JPY
Amortization of goodwill ope cfPrior1InterimDuration97000000JPY
Amortization of goodwill ope cfInterimDuration92000000JPY
Reversal of environmental measures ope cfPrior1InterimDuration-JPY
Reversal of environmental measures ope cfInterimDuration-73000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2025-03-31pass
balance sheet identityconsolidated 2025-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2025-03-31pass
statement vs summary · net assetsconsolidated 2025-09-30pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2024-09-30pass
statement vs summary · net income attributable to parentconsolidated 2025-04-01/2025-09-30pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2024-09-30pass
statement vs summary · operating cash flowconsolidated 2025-04-01/2025-09-30pass
statement vs summary · revenueconsolidated 2024-04-01/2024-09-30pass
statement vs summary · revenueconsolidated 2025-04-01/2025-09-30pass
statement vs summary · total assetsconsolidated 2025-03-31pass
statement vs summary · total assetsconsolidated 2025-09-30pass